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A B S T R A C T
Adults with cerebral palsy (CP) are known to participate in reduced levels of total physical
activity. There is no information available however, regarding levels of moderate-to-
vigorous physical activity (MVPA) in this population. Reduced participation in MVPA is
associated with several cardiometabolic risk factors. The purpose of this study was ﬁrstly
to compare levels of sedentary, light, MVPA and total activity in adults with CP to adults
without CP. Secondly, the objective was to investigate the association between physical
activity components, sedentary behavior and cardiometabolic risk factors in adults with
CP. Adults with CP (n = 41) age 18–62 yr (mean  SD = 36.5  12.5 yr), classiﬁed in Gross
Motor Function Classiﬁcation System level I (n = 13), II (n = 18) and III (n = 10) participated in
this study. Physical activity was measured by accelerometry in adults with CP and in age- and
sex-matched adults without CP over 7 days. Anthropometric indicators of obesity, blood
pressure and several biomarkers of cardiometabolic disease were also measured in adults with
CP. Adults with CP spent less time in light, moderate, vigorous and total activity, and more
time in sedentary activity than adults without CP (p < 0.01 for all). Moderate physical activity
was associated with waist-height ratio when adjusted for age and sex (b = 0.314, p < 0.05).
When further adjustment was made for total activity, moderate activity was associated with
waist-height ratio (b = 0.538, p < 0.05), waist circumference (b = 0.518, p < 0.05), systolic
blood pressure (b = 0.592, p < 0.05) and diastolic blood pressure (b = 0.636, p < 0.05).
Sedentary activity was not associated with any risk factor. The ﬁndings provide evidence that
relatively young adults with CP participate in reduced levels of MVPA and spend increased
time in sedentary behavior, potentially increasing their risk of developing cardiometabolic
disease.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC1. Introduction
Although cerebral palsy (CP) is a non-progressive disorder, it is well reported that adults with CP experience a number of
secondary conditions with age. These include pain, fatigue, stiffness, and poor balance (Opheim, Jahnsen, Olsson, & Stanghelle,
2009; Van Der Slot et al., 2012), and can lead to a decline in physical functioning and loss of mobility from early adulthood.
Between 30% and 52% of adults with CP reported experiencing deterioration in walking function (Bottos, Feliciangeli, Sciuto,
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J.M. Ryan et al. / Research in Developmental Disabilities 35 (2014) 1995–20021996Gericke, & Vianello, 2001; Opheim et al., 2009). Loss of mobility is most commonly observed between the age of 20 and 40 years
(Bottos et al., 2001). Deterioration in physical functioning over time may lead to difﬁculties performing everyday activities and
potentially an inactive lifestyle.
Only two studies have objectively measured physical activity in adults with CP to date, with conﬂicting results
(Nieuwenhuijsen et al., 2009; van der Slot et al., 2007). Adults with unilateral spastic CP were reported to be as active as their
able-bodied peers (van der Slot et al., 2007), whereas adults with bilateral spastic CP were less active than their able-bodied
peers (Nieuwenhuijsen et al., 2009). Gross motor function was a strong predictor of physical activity in adults with bilateral
CP (Nieuwenhuijsen et al., 2009). Differences in the gross motor function between samples may therefore explain the
discrepancy in results.
Although these studies reported levels of total physical activity in adults with CP, information about time spent in
individual domains of activity, such as sedentary behavior, light activity (LPA) and moderate-to-vigorous activity (MVPA), is
not available. Decreased levels of MVPA and increased sedentary behavior are independently associated with risk factors for
cardiovascular disease (CVD) and type II diabetes mellitus (T2DM), including obesity, dyslipidemia, hypertension, insulin
resistance, hyperglycemia, and inﬂammatory markers (Healy, Matthews, Dunstan, Winkler, & Owen, 2011; Loprinzi et al.,
2013; Luke, Dugas, Durazo-Arvizu, Cao, & Cooper, 2011; Nelson et al., 2013). The current American College of Sports
Medicine (ACSM) guidelines recommend that adults accumulate 150 min of moderate activity (MPA) or 75 min of vigorous
activity (VPA), in bouts of at least 10 min, per week to reduce their risk of CVD and premature mortality (Garber et al., 2011).
The potentially increased risk of adults with CP developing T2DM or CVD, as a result of inactivity, has led to comparisons to
people with spinal cord injury – a population known to have insulin resistance, dyslipidemia, and an elevated presence of
T2DM (Bauman, 2009). Furthermore, a recent study reported that reduced MPA and increased sedentary behavior are
associated with an increased risk of the metabolic syndrome in adults with impaired mobility (Peterson, Al Snih, Stoddard,
Shekar, & Hurvitz, 2013). Despite this, no study has investigated habitual levels of MVPA and their association with
cardiometabolic risk factors in adults with CP.
The purpose of this study was two-fold. The ﬁrst objective was to compare levels of physical activity and sedentary
behavior between adults with and without CP. The second objective was to examine the relationship between physical
activity components, sedentary behavior and cardiometabolic risk factors in adults with CP.
2. Materials and methods
2.1. Participants
Adults with CP (n = 41), age 18–62 yr (mean  SD = 36.5  12.5 yr), classiﬁed in level I–III of the Gross Motor Function
Classiﬁcation System (GMFCS) participated in this study. This study was limited to ambulatory individuals only as accelerometers
are unable to quantify physical activity in wheelchair users (Hiremath & Ding, 2011). Participants were recruited from a national
centre that provides services to people with a disability and through general practitioners (GPs) nationwide. The database of the
centre was searched for eligible adults, resulting in 263 letters and study invitations being sent to potential participants. Letters
were sent to 1367 GPs asking them to pass on information leaﬂets and study invites to clients who were eligible to participate.
Physical activity data from age- and sex-matched adults without CP was obtained from an institutional database of physical
activity control data that was collected between 2009 and 2013. Adults with a severe intellectual disability and pregnant women
were excluded from participating in this study. Participants were informed of the testing procedures before written informed
consent was obtained. In the case of participants with a mild to moderate intellectual disability, their guardians also provided
written informed consent. Ethical approval for this study was granted by the University of Dublin’s Faculty of Health Sciences’
ethics committee and the Central Remedial Clinic’s ethics committee.
2.2. Procedures
Participants were classiﬁed according to the GMFCS and according to type of motor abnormality and anatomical
distribution as deﬁned by the Surveillance of Cerebral Palsy in Europe (Rosenbaum et al., 2007). Information was also
obtained from participants regarding their history of CVD and T2DM and current use of medication.
Height, body mass, body mass index (BMI), waist circumference (WC), waist-hip ratio (WHR), and waist-height ratio
(WHtR) were measured in participants. WC was measured, on bare skin, to the nearest 0.1 cm midway between the lower rib
margin and the iliac crest at the end of gentle expiration. HC was measured to the nearest 0.1 cm at the end of gentle
expiration around the maximum circumference of the buttocks. The mean of two measurements was used for both WC and
HC. Overweight and obesity were identiﬁed as a BMI  25 kg m2 and 30 kg m2, respectively. Central obesity was deﬁned
as WC  80 cm for women and 94 cm for men.
Blood pressure was measured from the right arm or the least affected side, in the case of signiﬁcant asymmetry, using the
Omron 705 IT BP monitor. The Omron 705 IT has demonstrated excellent validity in adults under the British Hypertension
Society criteria (El Assaad, Topouchian, & Asmar, 2003). The appropriate cuff size was selected for the participant based on
their mid-arm circumference and placed so that the lower edge was 3 cm above the elbow crease and the bladder was
centred over the brachial artery. Participants rested in a seated position with their back supported for at least 5 min before
three measurements were taken at a 1–2 min interval. The average of the last two measurements was used in data analysis.
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Biochemistry Department, St. James’s Hospital, Dublin. Participants were allowed to drink water during the fast and
medications for cardiovascular stability were permitted (i.e. anti-hypertensive medications). Insulin was measured by
electrochemiluminescence immunoassay (Elecsys Insulin Assay, Roche Diagnostics GMBH). Enzymatic, colorimetric
assays (Roche/Hitachi cobas c systems) were used to measure fasting glucose, total cholesterol (TC), high-density
lipoprotein cholesterol (HDL-C) and triglycerides. TC/HDL-C ratio was calculated as TC divided by HDL-C. Low-density
lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation (Friedewald, Levy, & Fredrickson, 1972).
High performance liquid chromatography (Arkray/Adams A1c HA-8160 Analyser System) was used to measure glycated
haemoglobin (HbA1c) and c-reactive protein (CRP) was measured by particle enhanced immunoturbidimetric assay
(Roche/Hitachi cobas c systems). High risk CRP was categorized as >0.3 mg dL1 (Pearson et al., 2003). 25-Hydroxy
vitamin D (25OHD) was measured on the API 4000 LC/MS/MS system (Norwolk, Connecticut). The Homeostasis Model
Assessment index (HOMA-IR) (Matthews et al., 1985) was used to evaluate insulin resistance. The metabolic syndrome
was deﬁned according to the most recent joint interim statement (Alberti et al., 2009), i.e. the presence of three or more
of the following: (1) central obesity, (2) elevated triglycerides (150 mg/dL [1.7 mmol L1]) or drug treatment for
elevated triglycerides, (3) reduced HDL-C (<40 mg/dL [1.0 mmol L1] in men; <50 mg/dL [1.3 mmol L1] in women) or
drug treatment for reduced HDL-C, (4) elevated blood pressure (systolic  130 and/or diastolic  85 mm Hg) or
antihypertensive drug treatment, and (5) elevated fasting glucose (100 mg/dL) or drug treatment for elevated
glucose.
Physical activity was measured using the RT3 accelerometer (Stayhealthy, Inc.). The following procedure was used to
collect physical activity data in adults with and without CP. All participants were asked to wear the RT3 for 7 days on their
right hip (or least affected side in the case of signiﬁcant asymmetry) in the midaxillary line. Participants were told to wear the
RT3 for waking hours and to remove it only for bathing and swimming. Participants were asked to record the times that they
removed the monitor and the activities they completed while not wearing the monitor. Vector magnitude count data was
collected in 1-min epochs.
Valid activity data was deﬁned as having at least four days data, of at least 10 h wear time per day (Ward, Evenson,
Vaughn, Rodgers, & Troiano, 2005). Sedentary activity was deﬁned as <100 countsmin1, light activity (LPA) was deﬁned as
100–984 countsmin1, moderate activity (MPA) was deﬁned as 984–2341 countsmin1, vigorous activity (VPA) was
deﬁned as >2341 countsmin1 (Rowlands, Thomas, Eston, & Topping, 2004). Data is presented as time spent in light,
moderate and vigorous activity accumulated in 1-min intervals, percentage time spent in sedentary activity (i.e. minutes
spent in sedentary activity/total wear time), and mean activity counts per minute (countsmin1). Time spent in MVPA
accumulated in 10-min bouts was also calculated. One minute of activity below the moderate activity count threshold was
allowed for before the bout was considered to be ended. Finally the percentage of adults with and without CP meeting the
ACSM recommendation was calculated.
2.3. Data analysis
Statistical analysis was performed using IBM SPSS Statistics (version 19). The distribution of the data was checked for
normality by the Kolmogorov–Smirnov test. The logarithm function was applied to HOMA-IR, TC/HDL-C ratio and 25OHD to
transform this data to a normal distribution. Means and standard deviations were computed for each of the normally
distributed continuous variables. Medians and interquartile ranges were computed for skewed data. Prevalence data is
presented as percentages.
Differences between continuous variables with a normal distribution were determined by independent t-tests and one-
way analysis of variance (ANOVA). Differences between continuous variables with a skewed distribution were determined
by Mann–Whitney U tests and Kruskal–Wallis one-way analysis of variance. Pearson’s x2 test was used for comparison of
independent groups of categorical data.
Multiple linear regression was used to investigate the association between cardiometabolic risk factors (i.e. BMI, WC,
WHtR, WHR, systolic blood pressure, diastolic blood pressure, TC, HDL-C, TC/HDL-C ratio, LDL-C, triglycerides, plasma
glucose, HbA1c, HOMA-IR, 25OHD) and physical activity components (percentage time in sedentary behavior, LPA, MPA, VPA,
MVPA, mean countsmin1). Collinearity was examined using variance inﬂation factors. All analyses were controlled for age
and sex.
To avoid multicollinearity, each independent variable (i.e. percentage time in sedentary behavior, LPA, MPA, VPA,
MVPA, and mean countsmin1) was entered in separate analyses. When systolic or diastolic blood pressure was the
dependent variable of interest the analysis was additionally controlled for anti-hypertensive medication (i.e. self-report
of taking any hypertension lowering medication coded as 1 if yes or 0 if no). When TC, HDL-C, LDL-C, or TC/HDL-C ratio
was the dependent variable of interest the analysis was also additionally controlled for drug therapy (i.e. self-reported
taking of any cholesterol medication coded as 1 if yes or 0 if no). These analyses were repeated additionally controlling
for total physical activity (mean countsmin1). Variance inﬂation factors <5 suggested that multicollinearity was not
an issue.
Logistic regression was conducted to investigate the association between the metabolic syndrome, high risk CRP
(dependent variables) and each physical activity component (independent variables). Analyses were initially controlled for
age and sex before additionally controlling for total activity. Statistical signiﬁcance was set at p < 0.05.
able 1
articipants’ physical and demographic characteristics by Gross Motor Function Classiﬁcation System level.
Total GMFCS level I GMFCS level II GMFCS level III
(n = 41) (n = 13) (n = 18) (n = 10)
n (%) n (%) n (%) n (%)
Male 19 (46.3) 9 (69.2) 7 (38.9) 3 (30.0)
Diagnostic classiﬁcation
Spastic cerebral palsy 37 (90.2) 13 (100.0) 14 (77.8) 10 (100.0)
Unilateral 15 (40.5) 10 (76.9) 4 (22.2) 1 (10.0)
Bilateral 22 (59.5) 3 (23.1) 10 (55.6) 9 (90.0)
Othera 4 (9.8) 0 (0.0) 4 (22.2) 0 (0.0)
a Data from non-spastic forms of CP were combined to form one group due to the small number of participants with ataxic, dystonic, or choreoathetoid CP.
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Time spent in sedentary behavior, light, moderate, vigorous, moderate-to-vigorous activity, and mean countsmin1 per day for adults with cerebral palsy
by Gross Motor Function Classiﬁcation System level.
GMFCS level I GMFCS level II GMFCS level III Total p value
M SD M SD M SD M SD
Sedentary behavior (min) 505.3 89.7 506.1 98.3 579.0 85.2 523.6 95.8 0.1082
Sedentary behavior (% of total wear-time) 61.95 9.87 60.95 9.79 69.17 10.35 63.27 10.28 0.1082
Light activity (min) 246.8 66.8 282.2 70.1 240.2 78.4 260.7 72.0 0.2411
Moderate activity (min) 45.5 17.5 37.7 28.0 16.2 14.0 33.3a 36.4 0.0105
Vigorous activity (min) 14.7a 27.4 4.3 3.1 1.2a 5.6 5.2a 7.4 0.0280
Mod-to-vig activity (min) 27.4 21.6 6.5a 17.0 0.0a 0.5 6.1a 23.4 0.0009
Mean countsmin1 278.7 122.6 214.3 82.5 147.0 74.3 218.3 105.4 0.0085
a Variable not normally distributed, data presented as median (IQR). Mod-to-vig, moderate-to-vigorous.3. Results
The characteristics of participants with CP are presented in Table 1. Both groups (i.e. adults with and without CP) wore the
RT3 for a median (IQR) of 7.0 (1.0) days. Adults with CP wore the RT3 for a median (IQR) time of 840.5 (88.5) min per day;
adults without CP wore the RT3 for a mean time of 841.2 (59.3) min per day. There was no signiﬁcant difference in wear time
between groups.
3.1. Physical activity and sedentary time in adults with and without CP
Time spent in MPA, VPA, and MVPA, and mean countsmin1 differed across GMFCS levels I, II and III, respectively (see
Table 2). Post hoc pairwise comparisons revealed that adults in level I spent more time in VPA and MVPA than adults in level
II, and more time in MPA, VPA, MVPA and total activity (mean countsmin1) than adults in level III (p < 0.01 for all). Adults in
level II spent more time in MPA than adults in level III (p < 0.05). Adults in level III spent more time in sedentary behavior
than adults in level II (p < 0.05). There were no other differences in physical activity components between GMFCS levels.
Adults with unilateral spastic CP spent less time in sedentary behavior and more time in MPA, VPA, MVPA and total activity
than adults with bilateral CP. Data from adults with non-spastic forms of CP were excluded from analyses due to the small
numbers of adults in this group (n = 4).
Overall, adults with CP spent more time in sedentary behavior (p < 0.001) and less time in LPA (p < 0.001), MPA
(p < 0.001), VPA (p < 0.01), MVPA (p < 0.001), and total activity (mean countsmin1) (p < 0.001) than adults without CP (see
Fig. 1). When analyzed according to GMFCS level, however, there was no difference in any physical activity outcome between
adults in GMFCS level I and age- and sex-matched control participants. A trend towards a signiﬁcant difference was observed
for VPA (p = 0.057). Adults in level II spent more time in sedentary behavior (p < 0.001), and less time in LPA and total activity
than control participants (p < 0.01). Time spent in MPA, VPA and MVPA did not differ between adults in GMFCS level II and
control participants. Adults in level III spent more time in sedentary behavior and less time in LPA, MPA, VPA, MVPA, and total
activity than control participants (p < 0.01 for all).
3.2. Adherence to physical activity guidelines among adults with and without CP
Ten adults with CP (24.4%) and 22 adults without CP (53.7%) met the ACSM guideline of 150 min of MVPA per week
(x2 = 7.38, p < 0.01). The number of adults meeting the guideline was signiﬁcantly less across worsening gross motor
function [GMFCS level I: n = 7 (53.8%); GMFCS level II: n = 3 (16.7%); GMFCS level III: n = 0 (0.0%); x2 = 9.92, p < 0.01].
Adherence to the guideline for vigorous activity was not calculated because of the small quantity of VPA accumulated by
adults with CP.
Fig. 1. Time spent in sedentary, light, moderate, vigorous and moderate-to-vigorous activity accumulated in 10 min bouts (MVPA), and mean counts per
minute, per day among adults with and without cerebral palsy. Error bars represent 95% conﬁdence intervals.
Table 3
Cardiometabolic risk factors among participants with cerebral palsy, presented across Gross Motor Function Classiﬁcation System level.
Total GMFCS level I GMFCS level II GMFCS level III
M SD M SD M SD M SD
BMI (kg m2) 24.5 3.6 24.7 3.8 24.4 3.0 24.2 4.5
WC (cm) 82.9 11.5 83.3 13.5 83.6 10.1 80.9 12.1
WHR 0.85 0.09 0.85 0.10 0.85 0.09 0.86 0.08
WHtR 0.51 0.07 0.49 0.07 0.51 0.06 0.52 0.07
Systolic BP (mm Hg) 126.6 13.9 127.2 17.2 127.1 14.6 125.0 7.6
Diastolic BP (mm Hg) 75.7 9.2 72.2 12.0 78.4 8.3 75.4 4.5
Total cholesterol (mmol L1) 4.63 0.88 4.38 0.92 4.89 0.93 4.49 0.68
HDL-cholesterol (mmol L1) 1.57 0.38 1.41 0.36 1.66 0.36 1.64 0.38
TC/HDL-C ratio 2.97 1.30 3.14 1.41 2.96 1.17 2.79 1.34
LDL-cholesterol (mmol L1) 2.66 0.76 2.54 0.84 2.84 0.71 2.50 0.74
Triglyceridesa (mmol L1) 0.80 0.42 0.95 0.51 0.81 0.25 0.75 0.29
Plasma glucosea (mg dL1) 84.6 10.8 84.6 9.6 85.5 9.6 81.9 9.6
HOMA-IR 1.87 1.76 1.72 1.73 1.92 1.94 2.02 1.47
HbA1c (mmol mol
1) 32.0 2.8 31.2 1.8 32.1 3.5 32.9 2.6
25OH vitamin D (nmol L1) 43.1 1.7 40.1 1.5 43.0 1.9 47.5 1.5
a Variable not normally distributed, data presented as median (IQR).
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Two adults (5%) were taking antihypertensive medication. Three adults (7.3%) were taking cholesterol medication. One
person reported a pre-diagnosis of type I diabetes mellitus. This person was removed from all analyses of blood biomarkers
of glucose metabolism (i.e. plasma glucose, HOMA-IR, HbA1c). A value for plasma glucose was missing for one person and the
HbA1c assay was missing for one person due to processing errors. Cardiometabolic risk factors across GMFCS level are
presented in Table 3. The prevalence of overweight/obesity was 41.5%, the prevalence of central obesity was 36.6%, the
prevalence of the metabolic syndrome was 20.5% and the prevalence of high risk CRP was 14.6%.
Regression models to show how physical activity components were associated with cardiometabolic risk factors are
presented in Table 4. Regression analysis revealed that when age and sex were adjusted for MPA was associated with WHtR.
When total activity was additionally controlled MPA remained associated with WHtR. Signiﬁcant associations were also
observed between MPA and WC, systolic blood pressure and diastolic blood pressure when adjusted for age, sex and total
activity. Logistic regression analysis revealed that neither physical activity nor sedentary behavior was associated with the
metabolic syndrome or high risk CRP.
4. Discussion
The results of the current study indicate that adults with CP spend more time in sedentary behavior and less time in light,
moderate, vigorous and total physical activity than adults without CP. Although previous studies have similarly reported
reduced levels of total activity among adults and children with CP (Maher, Williams, Olds, & Lane, 2007; Nieuwenhuijsen
Table 4
Multiple linear regression analyses to examine the contribution of moderate physical activity to cardiometabolic risk factors.
Dependent variable R2 Independent variables Standardized beta p-Value F
Waist-height ratio 0.377 Age 0.509 0.000 7.455**
Sex 0.381 0.008
Moderate physical activity 0.314 0.026
Waist-height ratio 0.400 Age 0.538 0.000 5.988**
Sex 0.384 0.007
Mean countsmin1 0.269 0.250
Moderate physical activity 0.538 0.028
Waist circumference 0.575 Age 0.455 0.000 12.171**
Sex 0.676 0.000
Mean countsmin1 0.386 0.054
Moderate physical activity 0.518 0.012
Systolic blood pressure 0.283 Age 0.308 0.047 2.756*
Sex 0.375 0.023
Antihypertensive medication 0.073 0.474
Mean countsmin1 0.523 0.048
Moderate physical activity 0.592 0.031
Diastolic blood pressure 0.293 Age 0.427 0.007 2.897*
Sex 0.045 0.777
Antihypertensive medication 0.154 0.322
Mean countsmin1 0.530 0.044
Moderate physical activity 0.636 0.020
* p < 0.05.
** p < 0.01.
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addition, this is ﬁrst study to demonstrate that a signiﬁcantly smaller proportion of adults with CP meet physical activity
guidelines compared to adults without CP. MPA was negatively associated with a number of cardiometabolic risk factors,
suggesting that this population is at increased risk of developing chronic disease as a result of reduced levels of activity.
Similar to previous studies of adults and children with CP (Bjornson, Belza, Kartin, Logsdon, & McLaughlin, 2007;
Nieuwenhuijsen et al., 2009), adults in level I accumulated comparable levels of physical activity to able-bodied adults. In
fact they accumulated a mean of 27.4 min of MVPA per day, resulting in over half of these adults meeting the guideline.
Adults in GMFCS level II, however, spent more time in sedentary behavior, and less time in LPA and total activity than adults
without CP. Interestingly, they accumulated similar levels of MPA, VPA and MVPA as control participants. It is possible that
adults with mild to moderate impairments participate in MVPA while attempting to keep up with their able-bodied peers
during everyday life. The combination of trying to balance the activity involved in daily life and the greater energetic cost of
locomotion associated with CP (Brehm, Becher, & Harlaar, 2007) may, however, result in an energy imbalance and chronic
fatigue, a primary complaint among adults with CP (Van Der Slot et al., 2012). Adults in level II may therefore reduce light
activity and increase sedentary behavior in an attempt to preserve energy. Despite achieving similar levels of MVPA as able-
bodied participants, it should be noted that, of concern, only 16.7% of adults in GMFCS level II met the physical activity
guideline.
As expected, adults in GMFCS level III participated in the least amount of physical activity; no adults in this group met the
physical activity guideline. As well as accumulating little or no MVPA they spent a large proportion of the day in sedentary
behavior. There is evidence in the general adult population that sedentary behavior is strongly associated with T2DM and
cardiometabolic risk factors, independent of time in MVPA (Healy et al., 2011; Stamatakis, Hamer, Tilling, & Lawlor, 2012). In
the current study however, sedentary behavior was not associated with any cardiometabolic risk factor. This may be because
the relationship between objectively measured sedentary behavior and cardiometabolic risk factors is less consistent than
that between self-reported sedentary behavior and risk factors (Stamatakis et al., 2012). Some research suggests that the
type of sedentary behavior, in particular TV-viewing, rather than the volume of sedentary behavior is associated with
cardiometabolic risk factors (Carson & Janssen, 2011; Stamatakis et al., 2012). This information was not captured by
accelerometry in the current study.
Although no association was observed between sedentary behavior and cardiometabolic risk factors, MPA was negatively
associated with a number of risk factors. This is in contrast to a recent study in Dutch adults with CP that was unable to ﬁnd
an association between physical activity and cardiovascular risk factors (van der Slot et al., 2013). This is likely because the
association between individual components of physical activity and risk factors was not investigated.
The association between physical activity and risk factors may be mediated through the effect of excess adiposity on
cardiometabolic disease. In the current study MPA was associated with measures of central adiposity but not BMI. Similarly,
anthropometric measures of central obesity, but not BMI, are associated with cardiometabolic risk factors in adults with CP
(Peterson, Haapala, & Hurvitz, 2012), probably because BMI is unable to identify excess adiposity in adults with impaired
mobility (Peterson et al., 2013). Future studies investigating the effect of exercise interventions in adults with CP should
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(Kay & Fiatarone Singh, 2006), and subsequent changes in cardiometabolic risk.
4.1. Limitations
There are a number of limitations to this study including the cross-sectional design, the inability to generalize the results
to non-ambulatory adults with CP, and the lack of dietary assessment. The studied sample was also relatively small. There is
currently no CP register in the Republic of Ireland and the majority of rehabilitative services are only provided up until age 18
years. International research reported that less than one-third of adults with CP are under the regular control of a
rehabilitation physician (Hilberink et al., 2007). Despite every effort being made to recruit adults for this study the relatively
low participation may have resulted in selection bias. In particular adults with an interest in preventive health and being
physically active may have been more likely to participate. As information was not available on adults who did not respond
to the study invite, comparisons cannot be made between responders and non-responders. The accelerometer used in this
study was also not water-proof and therefore was unable to measure physical activity accumulated during water sports.
Only 6 participants (14.6%) however, reported swimming for between 1 and 3 h per week.
5. Conclusion
The results of this study suggest that a large proportion of adults with CP do not meet physical activity guidelines. As well
as spending less time in total physical activity adults with CP spent less time in MPA and VPA, and more time in sedentary
behavior than their able-bodied peers. The negative association between MPA and cardiometabolic risk factors suggests that
policy and intervention should be implemented to increase MPA in adults with CP in order to reduce cardiometabolic disease
risk in this population.
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